Dystroglycan regulates structure, proliferation and differentiation of neuroepithelial cells in the developing vertebrate CNS

被引:29
作者
Schroeder, Joern E.
Tegeler, Marion R.
Grosshans, Uli
Porten, Elmar
Blank, Martina
Lee, Jun
Esapa, Chris
Blake, Derek J.
Kroeger, Stephan
机构
[1] Johannes Gutenberg Univ Mainz, Dept Physiol Chem, D-55099 Mainz, Germany
[2] Univ Oxford, Dept Pharmacol, Oxford OX1 3QT, England
关键词
muscular dystrophy; development; RNAi; dystrophin-associated protein complex; retina; axonal growth; stem cells;
D O I
10.1016/j.ydbio.2007.04.020
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
In the developing CNS alpha- and beta-dystroglycan are highly concentrated in the endfeet of radial neuroepithelial cells at the contact site to the basal lamina. We show that injection of anti-dystroglycan Fab fragments, knockdown of dystroglycan using RNAi, and overexpression of a dominant-negative dystroglycan protein by microelectroporation in neuroepithelial cells of the chick retina and optic tectum in vivo leads to the loss of their radial morphology, to hyperproliferation, to an increased number of postmitotic neurons, and to an altered distribution of several basally concentrated proteins. Moreover, these treatments also altered the oriented growth of axons from retinal ganglion cells and from rectal projection neurons. In contrast, expression of non-cleavable dystroglycan protein in neuroepithelial cells reduced their proliferation and their differentiation to postmitotic neurons. These results demonstrate that dystroglycan plays a key role in maintaining neuroepithelial cell morphology, and that interfering with dystroglycan function influences proliferation and differentiation of neuroepithelial cells. These data also suggest that an impaired dystroglycan function in neuroepithelial cells might be responsible for some of the severe brain abnormalities observed in certain forms of congenital muscular dystrophy. (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:62 / 78
页数:17
相关论文
共 76 条
[1]   Brain function in Duchenne muscular dystrophy [J].
Anderson, JL ;
Head, SI ;
Rae, C ;
Morley, JW .
BRAIN, 2002, 125 :4-13
[2]   Dystroglycan: from biosynthesis to pathogenesis of human disease [J].
Barresi, R ;
Campbell, KP .
JOURNAL OF CELL SCIENCE, 2006, 119 (02) :199-207
[3]   Correlations between terminal mitosis and differentiated fate of retinal precursor cells in vivo and in vitro: Analysis with the ''window-labeling'' technique [J].
BeleckyAdams, T ;
Cook, B ;
Adler, R .
DEVELOPMENTAL BIOLOGY, 1996, 178 (02) :304-315
[4]   Mutations in the O-mannosyltransferase gene POMT1 give rise to the severe neuronal migration disorder Walker-Warburg syndrome [J].
Beltran-Valero de Bernabé, D ;
Currier, S ;
Steinbrecher, A ;
Celli, J ;
van Beusekom, E ;
van der Zwaag, B ;
Kayserili, H ;
Merlini, L ;
Chitayat, D ;
Dobyns, WB ;
Cormand, B ;
Lehesjoki, AE ;
Cruces, J ;
Voit, T ;
Walsh, CA ;
van Bokhoven, H ;
Brunner, HG .
AMERICAN JOURNAL OF HUMAN GENETICS, 2002, 71 (05) :1033-1043
[5]   DIFFERENT DISTRIBUTIONS OF DYSTROPHIN AND RELATED PROTEINS AT NERVE MUSCLE JUNCTIONS [J].
BEWICK, GS ;
NICHOLSON, LVB ;
YOUNG, C ;
ODONNELL, E ;
SLATER, CR .
NEUROREPORT, 1992, 3 (10) :857-860
[6]   β-dystrobrevin, a member of the dystrophin-related protein family [J].
Blake, DJ ;
Nawrotzki, R ;
Loh, NY ;
Górecki, DC ;
Davies, KE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (01) :241-246
[7]   The neurobiology of Duchenne muscular dystrophy:: learning lessons from muscle? [J].
Blake, DJ ;
Kröger, S .
TRENDS IN NEUROSCIENCES, 2000, 23 (03) :92-99
[8]   Molecular diversity of the dystrophin-like protein complex in the developing and adult avian retina [J].
Blank, M ;
Blake, DJ ;
Kröger, S .
NEUROSCIENCE, 2002, 111 (02) :259-273
[9]  
Blank M, 1997, J COMP NEUROL, V389, P668
[10]   A synthetic peptide corresponding to the 550-585 region of α-dystroglycan binds β-dystroglycan as revealed by NMR spectroscopy [J].
Bozzi, M ;
Veglia, G ;
Paci, M ;
Sciandra, F ;
Giardina, B ;
Brancaccio, A .
FEBS LETTERS, 2001, 499 (03) :210-214